Weitzman Aaron 4
4 · Tango Therapeutics, Inc. · Filed Dec 5, 2022
Insider Transaction Report
Form 4
Weitzman Aaron
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-12-01+350,000→ 350,000 totalExercise: $7.73Exp: 2032-12-01→ Common Stock (350,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on December 1, 2023, with the remaining option shares vesting in 36 equal monthly installments thereafter.